Mooi J, Chionh F, Savas P, Da Gama Duarte J, et al. Dual anti-angiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II study. Clin Cancer Res 2021 Jan 29. pii: 1078-0432.CCR-20-2714.
PMID: 33514526